XTNT — Xtant Medical Holdings, Inc.

NYSE · Health Care · Health Care Equipment & Supplies · CIK 1453593 ·
Last close
$0.46
Market Cap
$64.69M
52W High
$0.71
52W Low
$0.44
ADV30
152,330
Next earnings
2026-08-12
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers cervical products comprising Spider cervical plating, Streamline OCT system, and CervAlign systems; thoracolumbar products, such as of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; Silex sacroiliac joint fusion systems; interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; Contact ALP (Anterior Lumbar Plate) System; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. The company is headquartered in Belgrade, Montana.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 20,884,000 11,971,000 -2,923,000 -3,089,000 78,000,000 12,137,000 29,401,000
Dec 2025 32,357,000 17,754,000 -944,000 57,000 94,145,000 17,053,000 43,192,000
Sep 2025 33,255,000 21,992,000 2,541,000 1,308,000 106,321,000 10,400,000 55,938,000
Jun 2025 35,411,000 24,284,000 4,624,000 3,550,000 103,479,000 6,923,000 54,977,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$12,546,000
Investing CF
$7,899,000
Financing CF
$-9,570,000
CapEx
$-2,382,000
Dividends Paid
Buybacks
EPS Diluted TTM
$0.03
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-254,486,000
Inventory
$30,263,000
Receivables
$28,265,000
ST Investments
EBIT TTM
$10,672,000
Pretax Income TTM
$7,001,000
Interest Exp TTM
$3,671,000
Analysts
2

Yahoo Snapshot (yfinance, live)

Total Revenue
$121,907,000
EBITDA
$7,981,000
Free Cash Flow
$16,198,625
Enterprise Value
$70,531,768
Total Cash
$12,137,000
Total Debt
$15,436,000
Shares Out
140,262,960
Trailing EPS
$0.01
Book Value
$0.35
ROE
3.9%
ROA
2.4%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 133,927,000 7,284,000 4,973,000 94,145,000 43,192,000 12,546,000
Dec 2024 117,267,000 -12,074,000 -16,449,000 93,837,000 50,874,000 -11,896,000
Dec 2023 91,303,000 -10,158,000 660,000 92,612,000 41,263,000 -9,515,000
Dec 2022 57,969,000 -6,755,000 -8,485,000 60,229,000 26,058,000 -5,341,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-0.01

Peers — same industry

TickerNameMarket CapLastDaily %
HCIL Hongchang International Co., Ltd $64.85M $0.12
QTI QT IMAGING HOLDINGS, INC. $65.55M $4.95
LUNG Pulmonx Corp $66.31M $1.57
APT ALPHA PRO TECH LTD $61.81M $6.05
POSC POSITRON CORP $60.76M $1.85

News headlines (Yahoo Finance, 1h cache)

Xtant Medical Q1 Earnings Call Highlights
2026-05-16 02:05 · Yahoo
Xtant Medical Holdings, Inc. Q1 2026 Earnings Call Summary
2026-05-14 00:39 · Yahoo
Xtant Medical Holdings Inc (XTNT) Q1 2026 Earnings Call Highlights: Navigating Challenges and ...
2026-05-13 23:01 · Yahoo
Xtant Medical Hldgs Q1 2026 Earnings Call Transcript
2026-05-13 13:50 · Yahoo
Xtant Medical Reports First Quarter 2026 Financial Results
2026-05-13 11:00 · Yahoo
Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026
2026-05-07 12:00 · Yahoo
Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped
2026-05-06 12:00 · Yahoo
3 Promising Penny Stocks With Market Caps Under $200M
2026-04-30 18:05 · Yahoo
Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product
2026-04-13 13:04 · Yahoo
Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial
2026-04-09 12:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.